Cancer Cytopathology

Cover image for Vol. 125 Issue 10

Edited By: Celeste N. Powers, MD, PhD

Impact Factor: 3.818

ISI Journal Citation Reports © Ranking: 2016: 14/79 (PATHOLOGY); 14/79 (Pathology); 73/217 (ONCOLOGY); 73/217 (Oncology)

Online ISSN: 1934-6638

Associated Title(s): Cancer, CA: A Cancer Journal for Clinicians

Editorial Board


Editor-in-Chief 
Celeste N. Powers, MD, PhD*
Virginia Commonwealth University
Richmond, Virginia

Staff 

Esmeralda Galán Buchanan,
Senior Director, Journals and Books Publishing

Daniel Nadolny,
Managing Editor

Associate Editors 

Gilda da Cunha Santos, MD, PhD
Molecular Minute Editor
Cytopathology Help Desk Editor
University Health Network
Toronto, Canada

Martha Bishop Pitman, MD
Clinician's Corner Editor
Massachusetts General Hospital
Boston, Massachusetts

Esther Diana Rossi, MD, PhD, MIAC*
Catholic University of the Sacred Heart
Rome, Italy

Editorial Advisory Board 

Diane D. Davey, MD
Bridging the Gap Editor

Manon Auger, MD, FRCP(C)*
William C. Faquin, MD, PhD*
Andrew Field, MBBS, FRCPA, FIAC*
Jeffrey F. Krane, MD, PhD*

Yael K. Heher, MD, MPH*
QA Q&A Editor

Sharon Mount, MD*
Aziza Nassar, MD*
Ritu Nayar, MD*
Torill Sauer, MD, PhD*

David B. Kaminsky, MD, FIAC*
CytoSource Editor

Christopher VandenBussche, MD, PhD
Helen Wang, MD, DrPH*
Helene G. Wiener, MD, PhD*
David C. Wilbur

Dr. da Cunha Santos serves as a consultant for training in the assessment of PDL1 immunohistochemistry for Merck. She has no other financial relationships or interests to disclose.

Dr. Davey is a minor stock shareholder of Johnson & Johnson and Express Scripts. She has no other financial relationships to disclose.

Dr. Pitman serves as a consultant on needle design and research for Boston Scientific and Medtronic, Inc. She has no other financial relationships or interests to disclose.

Dr. VandenBussche serves as a consultant on processing and adequacy of pathology specimens for Personal Genome Diagnostics. He has no other financial relationships or interests to disclose.

Dr. Wilbur serves as a compensated consultant for Corista, and for Visiongate (for which he has received stock options.) He has no other financial relationships or interests to disclose.

*No financial relationships or interests to disclose.


EDITORIAL REVIEW BOARD

Zubair W. Baloch, MD, PhD
Ricardo H. Bardales, MD
Claudio Bellevicine, MD, PhD
Christine Bergeron, MD, PhD
George Birdsong, MD
Guoping Cai, MD
Joan Cangiarella, MD
Ivan A. Chebib, MD
Longwen Chen, MD
Sinchita Roy Chowdhuri, MD, PhD
William Crabtree, PhD
Catherine I. Dumur, PhD
Tarik Elsheikh, MD
Armando C. Filie, MD

Yun Gong, MD
Michael Idowu, MD, MPH
Chris Jensen, MD
Kusum Kapila, MBBS, MD, FRCPath, FIAC
Jerzy Klijanienko, MD, PhD, MIAC
Adele O. Kraft, MD
Savitri Krishnamurthy, MD
Xiaoqi Lin, MD, PhD
Britt-Marie E. Ljung, MD
Sara Elizabeth Monaco, MD
Michiya Nishino, MD, PhD
Christopher N. Otis, MD
Liron Pantanowitz, MD
Ibrahim Ramzy, MD, FRCP

Andrew Renshaw, MD
Michael H. Roh, MD, PhD
Dorothy L. Rosenthal, MD, FIAC
Mauro Saieg, MD, PhD
Beatriz A. Salvagno, MD, PhD
Fernando Schmitt, MD, PhD
Mary Schwartz, MD
Mary K. Sidawy, MD
Momin Siddiqui, MD, FIAC
Giancarlo Troncone, MD, PhD
Philippe Vielh, MD, PhD, FIAC
Jack Yang, MD
Maureen F. Zakowski, MD


 

SEARCH

SEARCH BY CITATION